Patents by Inventor Jessie Farah Fecteau

Jessie Farah Fecteau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD30L ANTIBODIES AND USES THEREOF
    Publication number: 20240092923
    Abstract: Described herein are anti-CD30L antibodies and pharmaceutical compositions for the treatment of autoimmune diseases and disorders such inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC).
    Type: Application
    Filed: November 15, 2023
    Publication date: March 21, 2024
    Inventors: Jessie-Farah FECTEAU, Mark RENSHAW, Johan FRANSSON, Olivier LAURENT, Burton BARNETT
  • Anti-CD30L antibodies and uses thereof
    Patent number: 11866505
    Abstract: Described herein are anti-CD30L antibodies and pharmaceutical compositions for the treatment of autoimmune diseases and disorders such inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC).
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: January 9, 2024
    Assignees: PROMETHEUS BIOSCIENCES, INC., DR. FALK PHARMA GMBH
    Inventors: Jessie-Farah Fecteau, Mark Renshaw, Johan Fransson, Olivier Laurent, Burton Barnett
  • DETECTION AND QUANTIFICATION OF NATALIZUMAB
    Publication number: 20230417761
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Application
    Filed: May 5, 2023
    Publication date: December 28, 2023
    Inventors: Bradley T. MESSMER, Dina UZRI, Jessie-Farah FECTEAU
  • Detection and quantification of natalizumab
    Patent number: 11680948
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: June 20, 2023
    Assignee: ABREOS BIOSCIENCES, INC.
    Inventors: Bradley T. Messmer, Dina Uzri, Jessie-Farah Fecteau
  • ANTI-CD30L ANTIBODIES AND USES THEREOF
    Publication number: 20230060624
    Abstract: Described herein are anti-CD30L antibodies and pharmaceutical compositions for the treatment of autoimmune diseases and disorders such inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC).
    Type: Application
    Filed: August 26, 2022
    Publication date: March 2, 2023
    Inventors: Jessie-Farah FECTEAU, Mark RENSHAW, Johan FRANSSON, Olivier LAURENT, Burton BARNETT
  • DETECTION AND QUANTIFICATION OF NATALIZUMAB
    Publication number: 20210285959
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Application
    Filed: August 11, 2017
    Publication date: September 16, 2021
    Inventors: Bradley T. MESSMER, Dina UZRI, Jessie-Farah FECTEAU
  • METHOD FOR POLYCLONAL IMMUNOGLOBULIN G PRODUCTION BY HUMAN B CELLS
    Publication number: 20140178361
    Abstract: This application relates to an in vitro method of producing a polyclonal IgG preparation. The method comprises (i) placing a polyclonal B-cell population enriched in IgG-secreting B cells in a culture medium; and (ii) culturing the polyclonal B-cell population under conditions enabling the production of the polyclonal IgG preparation from the polyclonal B-cell population. This improved method enables the production of antibodies (preferably IgG) and facilitates long-term culture of polyclonal B-cell populations.
    Type: Application
    Filed: February 28, 2014
    Publication date: June 26, 2014
    Applicants: Héma-Québec, Université Laval
    Inventors: Sonia Neron, Annie Roy, Jessie Farah Fecteau
  • Method for polyclonal immunoglobulin G production by human B cells
    Patent number: 8703486
    Abstract: This application relates to an in vitro method of producing a polyclonal IgG preparation. The method comprises (i) placing a polyclonal B-cell population enriched in IgG-secreting B cells in a culture medium; and (ii) culturing the polyclonal B-cell population under conditions enabling the production of the polyclonal IgG preparation from the polyclonal B-cell population. This improved method enables the production of antibodies (preferably IgG) and facilitates long-term culture of polyclonal B-cell populations.
    Type: Grant
    Filed: August 17, 2009
    Date of Patent: April 22, 2014
    Assignees: Université Laval, Héma-Québec
    Inventors: Sonia Néron, Annie Roy, Jessie Farah Fecteau
  • Point-of-care diagnostic device
    Patent number: D800912
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: October 24, 2017
    Assignee: ABREOS BIOSCIENCES, INC.
    Inventors: Dina Uzri, Benedict L. Zin, Bradley Todd Messmer, Inhoe Kim, Gad Shaanan, Jessie-Farah Fecteau